Validation of biomarkers of aging

M Moqri, C Herzog, JR Poganik, K Ying, JN Justice… - Nature medicine, 2024 - nature.com
The search for biomarkers that quantify biological aging (particularly 'omic'-based
biomarkers) has intensified in recent years. Such biomarkers could predict aging-related …

Proteomic signatures improve risk prediction for common and rare diseases

J Carrasco-Zanini, M Pietzner, J Davitte, P Surendran… - Nature medicine, 2024 - nature.com
For many diseases there are delays in diagnosis due to a lack of objective biomarkers for
disease onset. Here, in 41,931 individuals from the United Kingdom Biobank Pharma …

Proteomic aging clock (PAC) predicts age‐related outcomes in middle‐aged and older adults

CL Kuo, Z Chen, P Liu, LC Pilling, JL Atkins… - Aging cell, 2024 - Wiley Online Library
Beyond mere prognostication, optimal biomarkers of aging provide insights into qualitative
and quantitative features of biological aging and might, therefore, offer useful information for …

[HTML][HTML] Promises and challenges of populational proteomics in health and disease

BB Sun, K Suhre, BW Gibson - Molecular & Cellular Proteomics, 2024 - Elsevier
Advances in proteomic assay technologies has significantly increased coverage and
throughput, enabling recent increases in the number of large-scale population-based …

Cardiovascular risk prediction using metabolomic biomarkers and polygenic risk scores: A cohort study and modelling analyses

SC Ritchie, X Jiang, L Pennells, Y Xu, C Coffey, Y Liu… - medRxiv, 2023 - medrxiv.org
Metabolomic platforms using nuclear magnetic resonance (NMR) spectroscopy can now
rapidly quantify many circulating metabolites which are potential biomarkers of …

DNAm scores for serum GDF15 and NT-proBNP levels associate with a range of traits affecting the body and brain

DA Gadd, HM Smith, D Mullin, O Chybowska… - Clinical …, 2024 - Springer
Background Plasma growth differentiation factor 15 (GDF15) and N‐terminal proB‐type
natriuretic peptide (NT‐proBNP) are cardiovascular biomarkers that associate with a range …

Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes

P Yao, A Iona, A Pozarickij, S Said, N Wright… - Diabetes …, 2024 - Am Diabetes Assoc
OBJECTIVE Integrated analyses of plasma proteomics and genetic data in prospective
studies can help assess the causal relevance of proteins, improve risk prediction, and …

Plasma proteomic profiles of UK Biobank participants with multiple sclerosis

BM Jacobs, N Vickaryous, G Giovannoni… - Annals of Clinical …, 2024 - Wiley Online Library
Objective We aimed to describe plasma protein biomarkers of multiple sclerosis risk and to
explore protein biomarkers of disease severity using radiological outcome measures …

Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization

R Mao, T Zhang, Z Yang, J Li - Psoriasis: Targets and Therapy, 2024 - Taylor & Francis
Background Current pharmacological treatments for psoriasis are generally non-specific
and have significant limitations, particularly in the realm of targeted biologic therapies. There …

Epigenetic contributions to clinical risk prediction of cardiovascular disease

AD Chybowska, DA Gadd, Y Cheng… - Circulation: Genomic …, 2024 - Am Heart Assoc
BACKGROUND: Cardiovascular disease (CVD) is among the leading causes of death
worldwide. The discovery of new omics biomarkers could help to improve risk stratification …